Finance

Lists
950220:KOSDAQ
Neoimmunetech Inc
₩1,460.00
-1.68%
(-25.00) 1D
Nov 18, 11:09:13 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 950220...
Open
₩1,488
High
₩1,508
Low
₩1,451
Mkt. cap
51.11B
Avg. vol.
132.37K
Volume
21.59K
52-wk high
₩4,450
52-wk low
₩501
EPS
-₩1,264
Shares outstanding
34.21M
No. of employees
42
Open
₩1,488
High
₩1,508
Low
₩1,451
Mkt. cap
51.11B
Avg. vol.
132.37K
Volume
21.59K
52-wk high
₩4,450
52-wk low
₩501
EPS
-₩1,264
Shares outstanding
34.21M
No. of employees
42
News stories
From web sources and news partners
ING Sprinters
ING Sprinters
·
7 hours ago
De AEX Index breekt steun
ZeelandNet, startpagina van Zeeland
ZeelandNet, startpagina van Zeeland
·
7 hours ago
AEX-index lager, chipbedrijven dalen in aanloop cijfers Nvidia
About Neoimmunetech Inc
CEOSe Hwan Yang
Employees42
Founded2014
HeadquartersRockville, Maryland, United States
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
38.78M
533.70M
1.15B
4.88B
Cost of goods sold
-
-
246.62M
1.96B
Cost of revenue
-
-
246.62M
1.96B
Research and development expenses
-
3.67B
-3.67B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.52B
2.74B
7.61B
6.09B
Operating expense
6.28B
6.86B
4.99B
7.00B
Total operating expenses
6.28B
6.86B
5.24B
8.95B
Operating income
-6.24B
-6.33B
-4.09B
-4.07B
Other non operating income
-1.58B
-655.65M
4.20B
128.00K
EBT including unusual items
-10.68B
-7.64B
-335.09M
-4.15B
EBT excluding unusual items
-10.85B
-7.64B
-312.58M
-4.15B
Income tax expense
38.56M
-
-1.12M
-16.00K
Effective tax rate
-0.36%
-
0.33%
-
Other operating expenses
-
-
-
-
Net income
-10.72B
-7.64B
-333.97M
-4.15B
Net profit margin
-27,627.98%
-1,431.91%
-29.14%
-85.06%
Earnings per share
-
-
-
-
Interest and investment income
1.26B
406.72M
358.68M
343.19M
Interest expense
-2.42B
-621.13M
-584.65M
-622.25M
Net interest expenses
-1.17B
-214.41M
-225.97M
-279.06M
Depreciation and amortization charges
432.76M
218.96M
676.86M
375.99M
EBITDA
-5.62B
-5.70B
-3.33B
-3.39B
Gain or loss from assets sale
-213.95M
-
24.48M
-2.90M
Upcoming events
AI content may include mistakes. Learn more
Google apps